Armes Joseph B 4
4 · CSW INDUSTRIALS, INC. · Filed May 27, 2026
Research Summary
AI-generated summary of this filing
CSW Industrials CEO Joseph Armes Sells 1,500 Shares
What Happened
Joseph B. Armes, Chairman, President & CEO of CSW Industrials (CSW), disposed of 1,500 shares on May 27, 2026 in an open‑market sale. The weighted average sale price was $283.94 per share, generating proceeds of approximately $425,913. The sale was effected pursuant to a 10b5‑1 trading plan established August 12, 2025.
Key Details
- Transaction date: May 27, 2026 (reported on the same date).
- Sale type/code: Open‑market sale (S).
- Shares sold: 1,500; weighted average price: $283.94; total proceeds ≈ $425,913.
- Price range: sales occurred at prices between $281.565 and $284.75 (weighted average reported). (Footnote F2)
- 10b5‑1 plan: Trade executed under a prearranged 10b5‑1 plan (Footnote F1).
- Shares owned after the transaction: Not specified in the provided filing excerpt.
- Filing timeliness: Filed on the period date (May 27, 2026) — no late filing indicated.
Context
A 10b5‑1 trading plan allows insiders to set up preplanned trades, which can make such sales routine and less indicative of contemporaneous insider sentiment. The same filing includes several footnotes (F3–F7, F7) describing outstanding performance rights and restricted stock units that may convert to shares in the future, but those awards were not part of this sale.
Insider Transaction Report
Form 4
Armes Joseph B
DirectorChairman, President & CEO
Transactions
- Sale
Common Stock
[F1][F2]2026-05-27$283.94/sh−1,500$425,913→ 70,600 total
Holdings
- 3,219(indirect: by ESOP)
Common Stock
- 9,836
Performance Rights
[F3]→ Common Stock (9,836 underlying) - 8,004
Performance Rights
[F4]→ Common Stock (8,004 underlying) - 8,236
Performance Rights
[F5]→ Common Stock (8,236 underlying) - 9,186
Performance Rights
[F6]→ Common Stock (9,186 underlying) - 19,685
Restricted Stock Units
[F7]→ Common Stock (19,685 underlying)
Footnotes (7)
- [F1]The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 12, 2025.
- [F2]The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $281.565 to $284.75, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 250% during a three-year performance cycle beginning on April 1, 2026 and ending on March 31, 2029 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- [F4]Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2025, and ending on March 31, 2028, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- [F5]Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024, and ending on March 31, 2027, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- [F6]Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200%, during a performance cycle beginning April 1, 2021 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- [F7]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at vesting. 40% of the restricted stock units vest no earlier than April 26, 2025 upon the successful recruitment and hiring of a successor Chief Executive Officer; the remaining 60% vest upon the successful first employment anniversary of a successor Chief Executive Officer.
Signature
/s/ Luke E. Alverson, Attorney-in-Fact for Joseph B. Armes|2026-05-27